Success Metrics

Clinical Success Rate
22.2%

Based on 2 completed trials

Completion Rate
22%(2/9)
Active Trials
0(0%)
Results Posted
300%(6 trials)
Terminated
7(78%)

Phase Distribution

Ph not_applicable
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

22.2%

2 of 9 finished

Non-Completion Rate

77.8%

7 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(2)
Terminated(7)

Detailed Status

Terminated7
Completed2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
22.2%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated778%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9